StudyFinder

Development of a RET-Specific Proteomic Assay from Circulating Tumor Cells in Lethal Prostate Cancer

Status: Recruiting

The goal of this study is to find a special protein in the blood of individuals with serious prostate cancer. Special tests look for this protein in their blood while they are getting their regular cancer treatments.

I'm interested

Sex: Male
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• diagnosis of metastatic castration resistant prostate cancer receiving a standard-of-care systemic therapy (e.g. abiraterone acetate, enzalutamide, darolutamide, or chemotherapy).
Exclusion Criteria:

• known HIV positivity and/or active Hepatitis B based on medical history
Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC), MCRPC, metastatic castration resistant prostate cancer

Study Contact: Skylar Mast - smast@umn.edu
Principal Investigator: Emmanuel Antonarakis
IRB Number: STUDY00023289

Back